approval
saveOPDIVO QVANTIG (NIVOLUMAB) — FDA approval
community read0 votes
Sponsor: BRISTOL-MYERS SQUIBB. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
same company · ±60 days · 5
- approvalnivolumab: OPDIVO (NIVOLUMAB) — FDA approvalMay 23, 2025
- approvalfedratinib: INREBIC (FEDRATINIB HYDROCHLORIDE) — FDA approvalMay 12, 2025
- approvalnivolumab: OPDIVO (NIVOLUMAB) — FDA approvalJul 1, 2025
- approvalnivolumab: OPDIVO (NIVOLUMAB) — FDA approvalApr 11, 2025
- approvalnivolumab: OPDIVO (NIVOLUMAB) — FDA approvalApr 8, 2025
comments(0)
5-min edit window · permanent after that